Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesCTDL algorithm estimates lung nodule cancer risk, reduces false positivesThe deep-learning (DL) tool reduced false-positive results by almost 40% and showed high cancer detection rates.Molecular ImagingNeuroinflammation persists for 2 years in long COVIDMRIChatGPT gathers momentum in MR imagingCTLow-dose CT ties emphysema to mortality in previous smokersMRIKeep calm: Booklets aim to conquer children's anxiety